Lewis score correlates more closely with fecal calprotectin than capsule endoscopy crohn's disease activity index

Digestive Diseases and Sciences

Volumn 57, Issue 4, 2012, Pages 987-993

  Koulaouzidis, Anastasios ^a   Douglas, Sarah ^a   Plevris, John N ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Biological markers; Capsule endoscopy; Fecal calprotectin; Inflammation; Intestine; Scoring method; Small

Indexed keywords

CALGRANULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAPSULE ENDOSCOPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; LEWIS SCORE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SMALL BOWEL CAPSULE ENDOSCOPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAPSULE ENDOSCOPY; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; INFLAMMATION; INTESTINE, SMALL; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84863429734     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1956-8     Document Type: Article

References (26)

1. Triester SL, Leighton JA, Leontiadis GI, et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with nonstricturing small bowel Crohn's disease. Am J Gastroenterol. 2006;101:954-964.
2. Kornbluth A, Colombel JF, Leighton JA, et al. ICCE. ICCE consensus for inflammatory bowel disease. Endoscopy. 2005; 37:1051-1054.
3. Lewis BS. Expanding role of capsule endoscopy in inflammatory bowel disease. World J Gastroenterol. 2008;14:4137-4141.
4. Lewis BS, Eisen GM, Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy. 2005;37:960-965.
5. Doherty GA, Moss AC, Cheifetz AS. Capsule endoscopy in suspected Crohn's disease: "yield" does not equal "diagnosis". Am J Gastroenterol. 2010;105:2111.
6. Roøseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol. 1992;27:793-798.
7. Logan R. Faecal calprotectin for the diagnosis of inflammatory bowel disease. BMJ. 2010;341:c3636. doi:10.1136/bmj.c3636.
8. Langhorst J, Elsenbruch S, Koelzer J, et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162-169.
9. Sipponen T, Björkesten CG, FärkkiläM, et al. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment. Scand J Gastroenterol. 2010;45:325-331.
10. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;341:c3369. doi: 10.1136/bmj.c3369.
11. Summerton CB, Longlands MG, Wiener K, et al. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol. 2002;14:841-845.
12. Lucendo AJ, Guagnozzi D. Small bowel video capsule endoscopy in Crohn's disease: what have we learned in the last ten years? World J Gastrointest Endosc. 2011;3:23-29.
13. Gal E, Geller A, Fraser G, et al. Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI). Dig Dis Sci. 2008;53:1933-1937.
14. Gralnek IM, Defranchis R, Seidman E, et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther. 2008;27: 146-154.
15. Koulaouzidis A, Douglas S, Rogers MA, et al. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bidirectional endoscopy. Scand J Gastroenterol. 2011;46:561-566.
16. Jensen MD, Kjeldsen J, Nathan T. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon. Scand J Gastroenterol. 2011;46:694-700.
17. Zippi M, Al Ansari N, Siliquini F, et al. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease. Clin Ter. 2010;161:e53-e56.
18. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:524-534.
19. Bourreille A, Ignjatovic A, Aabakken L, World Organisation of Digestive Endoscopy (OMED) and the European Crohn's and Colitis Organisation (ECCO), et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009;41:618-637.
20. Sidhu R, Sanders DS, Wilson P, et al. Faecal lactoferrin, capsule endoscopy and Crohn's disease. Is there a three way relationship? A pilot study. J Gastrointestin Liver Dis. 2010;19:257-260.
21. van Langenberg DR, Gearry RB, Wong HL, et al. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. Intern Med J. 2010;40:819-827.
22. Schoepfer AM, Beglinger C, Straumann A, et al. Non-invasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162-169.
23. Roøseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34: 50-54.
24. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000; 47:506-513.
25. Dolwani S, Metzner M, Wassell JJ, et al. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther. 2004;20:615-621.
26. Sprakes MB, Hamlin PJ, Ford AC. Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome. Am J Gastroenterol. 2011; 106:166.